Five Ways Our Scientists Are Working Toward a World Without Alzheimer’s
How institute scientists are working to understand the causes of Alzheimer's and designing potential new treatments.
How institute scientists are working to understand the causes of Alzheimer's and designing potential new treatments.
Drug-resistant malaria parasites cause 280 million infections and 600,000 deaths, mostly in small children. A rare natural product offers hope.
A new grant advances a strategy to durably lock HIV in its dormant state inside cells.
The Campbell Foundation funded the project because it tackles a major barrier to durable HIV therapies.
What scientists thought they knew about an important TB enzyme is wrong. "It acts in a completely different way," says Luiz Pedro Carvalho, Ph.D. His research appears in the journal PNAS.
AI can help us search enormous numbers of chemical structures. But it cannot look at a patient waiting for a medicine and decide which problem is worth a life's work.
A new screening approach developed in the lab of William Ja, Ph.D. is offering a new way to study the biology of aging.
The annual Kenan Fellows Summer Symposium gave students an opportunity to share their research and reflect on their experiences. See the photo gallery.
A new approach to "molecular glue" drug design snags an "undruggable" diabetes target.
Federal grants worth up to $7.4 million will boost research on treatments for mosquito-borne viral diseases.